A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1?+?PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOE?4 Carriers.
Ontology highlight
ABSTRACT: BACKGROUND:Trajectories of complex neurocognitive phenotypes in preclinical aging may be produced differentially through selective and interactive combinations of genetic risk. OBJECTIVE:We organize three possible combinations into a "network" of genetic risk indices derived from polymorphisms associated with normal and impaired cognitive aging, as well as Alzheimer's disease (AD). Specifically, we assemble and examine three genetic clusters relevant to non-demented cognitive trajectories: 1) Apolipoprotein E (APOE), 2) a Cognitive Aging Genetic Risk Score (CA-GRS; Catechol-O-methyltransferase + Brain-derived neurotrophic factor), and 3) an AD-Genetic Risk Score (AD-GRS; Clusterin + Complement receptor 1?+?Phosphatidylinositol-binding clathrin assembly protein). METHOD:We use an accelerated longitudinal design (n?=?634; age range?=?55-95 years) to test whether AD-GRS (low versus high) moderates the effect of increasing CA-GRS risk on executive function (EF) performance and change as stratified by APOE status (?4+ versus ?4-). RESULTS:APOE?4 carriers with high AD-GRS had poorer EF performance at the centering age (75 years) and steeper 9-year decline with increasing CA-GRS but this association was not present in APOE?4 carriers with low AD-GRS. CONCLUSIONS:APOE?4 carriers with high AD-GRS are at elevated risk of cognitive decline when they also possess higher CA-GRS risk. Genetic risk from both common cognitive aging and AD-related indices may interact in intensification networks to differentially predict (1) level and trajectories of EF decline and (2) potential selective vulnerability for transitions into impairment and dementia.
SUBMITTER: Sapkota S
PROVIDER: S-EPMC5830167 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA